Prevention strategies for herpes zoster and post-herpetic neuralgia
about
Evaluation of efficacy and effectiveness of live attenuated zoster vaccinePredictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapyEmerging drugs for varicella-zoster virus infections.One-year follow-up of patients with long-lasting post-herpetic neuralgia.Administration of Vitamin C in a Patient with Herpes Zoster - A case report -.Current gene therapy using viral vectors for chronic painIn vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis.A systematic review of the cost effectiveness of herpes zoster vaccination.Vaccination against and treatment of acute herpes zoster for prevention of post-herpetic neuralgia.Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns.The history and mystery of VZV in saliva.Trends, correlates, and disease patterns of antidepressant use among children and adolescents in Taiwan.A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.Reduced NK cell IFN-γ secretion and psychological stress are independently associated with herpes zoster.
P2860
Q26866473-3F34F24B-313B-49BE-8DB2-4DAED9E2AA4CQ33714978-AA9E947B-580C-4559-AC66-84607F7DF241Q34027426-F193668E-B12E-477B-9EE8-05F5F8B54B40Q34484576-F8F3DA54-723E-42EF-B8EB-5A44A03A8D7CQ35035869-3477C0F0-CF9E-4778-AA19-CA23B9387D5BQ35658521-A1D5D447-D02A-4CA9-A118-74521704812FQ35826062-26ADCEEE-7969-4DEB-B4FE-F15B8E83AE42Q36259299-F291E61B-B190-422D-8024-1BC132607FCEQ38075493-DC137236-1660-4C32-808B-004837B9106AQ38133446-A45E2F87-D9EE-4004-A793-FA78C5D69ED3Q40686391-3E69DC90-9EFF-4420-AA73-3D92031B21CBQ42869193-8E19F42D-C7C8-4790-8B6D-D68B72BDC1DCQ48638481-81759B2F-7053-46CF-88A9-E99C7FE97FC3Q49157618-D79867D9-5F6B-4926-8FB4-EEF947110BECQ52731228-F6204966-76DA-4618-AB2B-DB78EA793AE7
P2860
Prevention strategies for herpes zoster and post-herpetic neuralgia
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevention strategies for herpes zoster and post-herpetic neuralgia
@ast
Prevention strategies for herpes zoster and post-herpetic neuralgia
@en
Prevention strategies for herpes zoster and post-herpetic neuralgia.
@nl
type
label
Prevention strategies for herpes zoster and post-herpetic neuralgia
@ast
Prevention strategies for herpes zoster and post-herpetic neuralgia
@en
Prevention strategies for herpes zoster and post-herpetic neuralgia.
@nl
prefLabel
Prevention strategies for herpes zoster and post-herpetic neuralgia
@ast
Prevention strategies for herpes zoster and post-herpetic neuralgia
@en
Prevention strategies for herpes zoster and post-herpetic neuralgia.
@nl
P2093
P2860
P1476
Prevention strategies for herpes zoster and post-herpetic neuralgia
@en
P2093
Anne A Gershon
Lawrence Stanberry
Marc Brisson
Myron J Levin
Robert H Dworkin
P2860
P356
10.1016/S1386-6532(10)70004-4
P478
48 Suppl 1
P577
2010-05-01T00:00:00Z